2m 2m 2m 2m 2m 2m 2m
908 DEVICES (MASS)
NASDAQ
$8.66-$0.20 (-2.20%)
Price as of Jun 03, 2026 4:15 PM EDT- $318.0MMarket Cap
- 33.69%1-Year Change
- Medical DevicesIndustry
908 DEVICES (MASS)
$8.66-$0.20 (-2.20%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 43.3M -27.42% | 59.6M +18.72% | 50.2M +7.21% | 46.9M +11.01% | |
Cost of Revenue | 22.3M -25.02% | 29.8M +19.54% | 24.9M +19.58% | 20.8M +9.78% | |
Gross Profit | 28.4M -4.80% | 29.9M +17.91% | 25.3M -2.69% | 26.0M +12.01% | |
Sales and Marketing Expense | 38.5M -28.17% | 53.6M +16.16% | 46.2M +5.23% | 43.9M +36.12% | |
Research and Development Expense | -15.6M -38.91% | -25.5M +16.39% | -21.9M +24.98% | -17.5M +34.12% | |
Depreciation and Amortization Expense | 4.5M -4.63% | 4.7M +96.39% | 2.4M +47.71% | 1.6M +74.49% | |
Total Operating Expenses | 67.8M -36.34% | 106.6M +56.54% | 68.1M +10.87% | 61.4M +35.55% | |
Operating Profit | -39.4M -48.62% | -76.7M +79.42% | -42.8M +20.85% | -35.4M +60.32% | |
Interest Income | 4.1M -7.97% | 4.5M -30.65% | 6.5M +219.05% | 2.0M N/A | |
Interest Expense | N/A N/A | N/A N/A | -201,000 +55.81% | -129,000 -73.46% | |
Interest Income and Expense and Net | 4.1M -7.97% | 4.5M -28.43% | 6.3M +230.13% | 1.9M +491.36% | |
Total Nonoperating Income and Expense | 6.1M +43.69% | 4.2M -31.20% | 6.1M +237.99% | 1.8M +1,919.00% | |
Income before Taxes | -33.3M -54.00% | -72.5M +98.00% | -36.6M +3.47% | -35.4M +59.60% | |
Income Taxes | -66,000 -76.60% | -282,000 +33.65% | -211,000 +63.57% | -129,000 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 19.5M +126.99% | -72.2M +98.37% | -36.4M +8.45% | -33.6M +51.40% | |
Net Income from Continuing Operations Applicable to Common | -33.3M -54.09% | -72.5M +98.00% | -36.6M +9.08% | -33.6M +51.40% | |
Basic EPS and Net Income | 0.54 +125.47% | -2.12 +87.61% | -1.13 +5.61% | -1.07 +35.44% | |
Diluted EPS and Net Income | 0.54 +125.47% | -2.12 +87.61% | -1.13 +5.61% | -1.07 +35.44% | |
Basic Weighted Average Shares | 35.9M +5.35% | 34.1M +5.70% | 32.2M +2.37% | 31.5M +12.64% | |
Diluted Weighted Average Shares | 35.9M +5.35% | 34.1M +5.70% | 32.2M +2.37% | 31.5M +12.64% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 70.5M +60.15% | 44.0M -63.62% | 121.0M -35.76% | 188.4M -15.91% | |
Short-Term Investments | 42.5M +66.04% | 25.6M +3.76% | 24.6M N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 113.0M +62.31% | 69.6M -52.22% | 145.7M -22.68% | 188.4M -15.91% | |
Total Current Assets | 144.6M +40.27% | 103.1M -40.70% | 173.8M -19.40% | 215.6M -14.74% | |
Accumulated Depreciation | 4.4M -47.72% | 8.4M +41.79% | 5.9M +26.08% | 4.7M +36.41% | |
Property and Plant and Equipment and Net | 4.2M +23.71% | 3.4M +2.36% | 3.3M +8.40% | 3.1M +92.33% | |
Total Long-Term Assets | 471,000 -43.18% | 829,000 -40.32% | 1.4M +0.36% | 1.4M +12.70% | |
Total Assets | 190.1M +19.18% | 159.5M -21.43% | 203.0M -16.33% | 242.6M -7.02% | |
Income Taxes Payable | 2.0M +0.20% | 2.0M -16.84% | 2.4M -8.61% | 2.7M N/A | |
Total Short-Term Debt | N/A N/A | 15.0M 0.00% | 15.0M N/A | 0 -100.00% | |
Total Current Liabilities | 34.1M +35.45% | 25.1M +11.53% | 22.5M +17.28% | 19.2M +29.59% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 15.0M 0.00% | 15.0M 0.00% | |
Total Long-Term Liabilities | 30,000 -98.69% | 2.3M +311.53% | 555,000 0.00% | 555,000 +186.08% | |
Total Liabilities | 46.4M +3.32% | 44.9M +19.72% | 37.5M -27.89% | 52.0M +12.28% | |
Retained Earnings | -223.3M -8.03% | -242.8M +42.32% | -170.6M +27.12% | -134.2M +33.35% | |
Total Stockholders Equity | 143.7M +25.40% | 114.6M -30.76% | 165.5M -13.17% | 190.6M -11.19% | |
Total Shares Outstanding | 36.3M +3.49% | 35.1M +7.93% | 32.5M +2.07% | 31.9M +2.52% | |
Cash Flow | |||||
Cash from Operating Activities | -23.7M -21.68% | -30.2M +20.70% | -25.1M +19.73% | -20.9M -28.03% | |
Capital Expenditures | 955,000 +58.64% | 602,000 -70.56% | 2.0M 0.00% | 2.0M +177.48% | |
Cash from Investing Activities | 50.7M +209.56% | -46.3M +75.46% | -26.4M +67.01% | -15.8M +2,044.78% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -697,000 +85.37% | -376,000 -97.64% | -15.9M -1,451.57% | 1.2M -98.76% | |
Financials Ratio | |||||
Gross Margin | 48.42% -3.29% | 50.07% -0.68% | 50.41% -9.24% | 55.54% N/A | |
Operating Margin | -91.08% -29.20% | -128.65% +51.13% | -85.13% +12.72% | -75.52% N/A | |
Return on Assets | 11.15% +127.99% | -39.84% +143.86% | -16.34% +22.55% | -13.33% N/A | |
Return on Equity | 15.09% +129.27% | -51.56% +152.21% | -20.44% +23.41% | -16.57% N/A | |
Revenue Growth | -27.42% -246.48% | 18.72% +159.70% | 7.21% -34.52% | 11.01% N/A | |
Current Ratio | 4.24 +3.56% | 4.10 -46.83% | 7.71 -31.28% | 11.22 N/A | |
Cash Ratio | 2.07 +18.24% | 1.75 -67.38% | 5.37 -45.23% | 9.80 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 0.18 +130.37% | 0.08 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.15 +139.16% | 0.06 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow